EM Scope uses magnetic muscle training + RF heat to contract muscle, burn fat, and tighten skin in 3040 mins
The half-life of tirzepatide is approximately 5 days (around 120 hours) following subcutaneous administration
Understanding the difference in dosing for these formats is crucial for setting expectations
Impairing and monitoring glucose catabolite repression in L-carnitine biosynthesis
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 10506) by Elizabeth McDonald, MD, PhD, a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing breast radiologist at Penns Abramson Cancer Center
Regular monitoring of blood sugar levels is essential to ensure the medication is working effectively
